Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation

Haematologica

Volumn 93, Issue 8, 2008, Pages 1276-1278

  Platzbecker, Uwe ^a   Binder, Marc ^a   Schmid, Christoph ^c   Rutt, Claudia ^b   Ehninger, Gerhard ^a   Bornhäuser, Martin ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DKMS German Bone Marrow Donor Center   (Germany)

^c KLINIKUM AUGSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; CHILD; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; LETTER; MAJOR CLINICAL STUDY; MORTALITY; ORGAN DONOR; PERIPHERAL BLOOD STEM CELL; RELAPSE; SURVIVAL;

DISEASE PROGRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLAMMATION; INTERLEUKIN-6; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMBOLISM; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS; VON WILLEBRAND FACTOR;

EID: 48749106924     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12798     Document Type: Letter

References (13)

1. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A, Niederwieser D. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 2007;39:71-87.
2. Bosi A, Bartolozzi B, Guidi S. Allogeneic stem cell transplantation. Transplant Proc 2005;37:2667-9.
3. Kopp HG, Horger M, Faul C, Hartmann JT, Kanz L, Lang P, Vogel W. Granulocyte colony-stimulating factor-induced pulmonary hemorrhage in a healthy stem cell donor. J Clin Oncol 2007;25:3174-5.
4. Platzbecker U, Prange-Krex G, Bornhauser M, Koch R, Soucek S, Aikele P, et al. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion 2001;41:184-9.
5. Bennett CL, Evens AM, Andritsos LA, Balasubramanian L, Mai M, Fisher MJ, et al. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol 2006;135:642-50.
6. Bacigalupo A, Lamparelli T, Gualandi F, Occhini D, Bregante S, Raiola AM, et al. Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcome. Bone Marrow Transplant 2007;39:341-6.
7. Platzbecker U, Thiede C, Freiberg-Richter J, Helwig A, Mohr B, Prange G, et al. Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF. Ann Hematol 2001;80:144-9.
8. Bosi A, Laszlo D, Labopin M, Reffeirs J, Michallet M, Gluckman E, et al. Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. Acute Leukemia Working Party of the European Blood and Marrow Transplant Group. J Clin Oncol 2001;19:3675-84.
9. Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, et al. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant 2004;34:721-7.
10. Michallet M, Tanguy ML, Socié G, Thiébaut A, Belhabri A, Milpied N, et al. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de moelle (SFGM). Br J Haematol 2000;108:400-7.
11. Larocca A, Piaggio G, Podestà M, Pitto A, Bruno B, Di Grazia C, et al. A boost of CD34(+)-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. Haematologica 2006;91:935-40.
12. Barrett AJ, Locatelli F, Treleaven JG, Gratwohl A, Szydlo R, Zwaan FE. Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party. Br J Haematol 1991;79:567-74.
13. Kishi K, Takahashi S, Gondo H, Shiobara S, Kanamaru A, Kato S, et al. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Bone Marrow Transplant 1997;19:461-6.